Yik Jeon - Theragen Etex Managing Director
| 066700 Stock | KRW 3,135 125.00 4.15% |
Managing Director
Jeon Yik Hwan serves as Managing Director of THERAGEN ETEX CO., LTD. Jeon was Chief Executive Officer of KOREA ETEX, Inc. Jeon also worked for ILYANG PHARMACEUTICAL CO., LTD and DAEWOONG PHARMA.
| Age | 51 |
| Phone | 82 2 3463 1110 |
| Web | https://www.theragenetex.com |
Theragen Etex Management Efficiency
The company has return on total asset (ROA) of (0.0115) % which means that it has lost $0.0115 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 3.4557 %, meaning that it generated $3.4557 on every $100 dollars invested by stockholders. Theragen Etex's management efficiency ratios could be used to measure how well Theragen Etex manages its routine affairs as well as how well it operates its assets and liabilities.Management Performance
| Return On Equity | 3.46 | |||
| Return On Asset | -0.0115 |
Theragen Etex CoLtd Leadership Team
Elected by the shareholders, the Theragen Etex's board of directors comprises two types of representatives: Theragen Etex inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Theragen. The board's role is to monitor Theragen Etex's management team and ensure that shareholders' interests are well served. Theragen Etex's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Theragen Etex's outside directors are responsible for providing unbiased perspectives on the board's policies.
| JinYeob Go, Chief Officer | ||
| Tae Hwang, Co-Chief Executive Officer, Director | ||
| Seong Lee, Internal Auditor | ||
| Wook Cho, Non-Executive Independent Director | ||
| Byeong Ryu, Co-Chief Executive Officer, Director | ||
| Byeong Kim, Vice President Director | ||
| Yun Son, Assistant Managing Director | ||
| Yik Jeon, Managing Director | ||
| Yeong Jin, Assistant Managing Director | ||
| Cho HyungSeok, Managing Director | ||
| Jong Park, Director | ||
| Seong Kim, Chief Technology Officer, Director | ||
| Wuk Cho, Non-Executive Independent Director | ||
| Jae Gwon, Vice President | ||
| Tae Park, Non-Executive Independent Director | ||
| Yeong Gwon, Non-Executive Independent Director | ||
| Seok Kang, Vice President | ||
| Jin Goh, Co-Chief Executive Officer, Director | ||
| Sang Kim, President | ||
| Su Woo, Internal Auditor | ||
| Geon Choi, Non-Executive Independent Director |
Theragen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Theragen Etex a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 3.46 | |||
| Return On Asset | -0.0115 | |||
| Profit Margin | (0.06) % | |||
| Operating Margin | (0.05) % | |||
| Current Valuation | 298.28 B | |||
| Shares Outstanding | 30.48 M | |||
| Shares Owned By Insiders | 16.91 % | |||
| Shares Owned By Institutions | 1.39 % | |||
| Price To Earning | 65.80 X | |||
| Price To Sales | 0.77 X |
Pair Trading with Theragen Etex
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Theragen Etex position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Theragen Etex will appreciate offsetting losses from the drop in the long position's value.Moving together with Theragen Stock
The ability to find closely correlated positions to Theragen Etex could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Theragen Etex when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Theragen Etex - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Theragen Etex CoLtd to buy it.
The correlation of Theragen Etex is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Theragen Etex moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Theragen Etex CoLtd moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Theragen Etex can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Theragen Stock
Theragen Etex financial ratios help investors to determine whether Theragen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Theragen with respect to the benefits of owning Theragen Etex security.